Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study.
Mulyukov Z, Keane PA, Sahni J, Liakopoulos S, Hatz K, Wei Ting DS, Gallego-Pinazo R, Aslam T, Gemmy Cheung CM, De Salvo G, Semoun O, Somfai GM, Stahl A, Lujan BJ, Lorand D. Mulyukov Z, et al. Among authors: lorand d. Ophthalmol Sci. 2024 Jun 17;4(6):100565. doi: 10.1016/j.xops.2024.100565. eCollection 2024 Nov-Dec. Ophthalmol Sci. 2024. PMID: 39253548 Free PMC article.
Does real-time artificial intelligence-based visual pathology enhancement of three-dimensional optical coherence tomography scans optimise treatment decision in patients with nAMD? Rationale and design of the RAZORBILL study.
Holz FG, Abreu-Gonzalez R, Bandello F, Duval R, O'Toole L, Pauleikhoff D, Staurenghi G, Wolf A, Lorand D, Clemens A, Gmeiner B. Holz FG, et al. Among authors: lorand d. Br J Ophthalmol. 2023 Jan;107(1):96-101. doi: 10.1136/bjophthalmol-2021-319211. Epub 2021 Aug 6. Br J Ophthalmol. 2023. PMID: 34362776 Free PMC article. Review.
A framework to guide dose & regimen strategy for clinical drug development.
Sander O, Magnusson B, Ludwig I, Jullion A, Meille C, Lorand D, Bornkamp B, Hinder M, Kovacs SJ, Looby M. Sander O, et al. Among authors: lorand d. CPT Pharmacometrics Syst Pharmacol. 2021 Nov;10(11):1276-1280. doi: 10.1002/psp4.12701. Epub 2021 Sep 25. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34562310 Free PMC article.
Robust ΔΔct estimate.
Kumar A, Lorand D. Kumar A, et al. Among authors: lorand d. Genomics. 2021 Jan;113(1 Pt 1):420-427. doi: 10.1016/j.ygeno.2020.12.009. Epub 2020 Dec 9. Genomics. 2021. PMID: 33309766 Free article.
Effect of various diuretic treatments on rosiglitazone-induced fluid retention.
Karalliedde J, Buckingham R, Starkie M, Lorand D, Stewart M, Viberti G; Rosiglitazone Fluid Retention Study Group. Karalliedde J, et al. Among authors: lorand d. J Am Soc Nephrol. 2006 Dec;17(12):3482-90. doi: 10.1681/ASN.2006060606. Epub 2006 Nov 8. J Am Soc Nephrol. 2006. PMID: 17093067 Clinical Trial.